Abacavir

NDC 50268-049 · AvPAK

Generic nameAbacavir

Dosage formTABLET

RouteORAL

Active ingredient(s)ABACAVIR SULFATE

Strength300 mg/1

Pharmacologic classCytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]

Marketing categoryANDA

Packages

50268-049-12 — 20 BLISTER PACK in 1 BOX (50268-049-12) / 1 TABLET in 1 BLISTER PACK (50268-049-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0378-4105 — abacavir sulfate, 0904-6874 — Abacavir, 31722-557 — Abacavir, 31722-562 — Abacavir, 31722-838 — ABACAVIR and LAMIVUDINE, 33342-440 — Abacavir and Lamivudine, 42385-962 — Abacavir and Lamivudine, 48433-001 — abacavir sulfate, 49702-222 — abacavir sulfate, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 51079-204 — abacavir sulfate, 64980-405 — Abacavir Sulfate, 65862-073 — Abacavir, 65862-089 — Abacavir Sulfate, 65862-335 — Abacavir and Lamivudine, 67046-1602 — Abacavir, 68084-021 — Abacavir, 68180-286 — ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, 68180-288 — Abacavir and Lamivudine, 69097-362 — Abacavir and lamivudine, +2 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.